Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mehnert

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|March 4, 2000
Solid lipid nanoparticles as drug carriers for topical glucocorticoidsC S Maia, W Mehnert, M Schäfer-Korting
Journal of Microencapsulation|July 21, 2006
Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLCE B Souto, W Mehnert, R H Müller
Journal of Drug Targeting|January 1, 1996
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407R H Müller, S Maassen, H Weyhers, et al.
Pharmaceutical Research|September 1, 1996
Atomic force microscopy studies of solid lipid nanoparticlesA zur Mühlen, E zur Mühlen, H Niehus, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 19, 2007
In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical useS Lombardi Borgia, P Schlupp, W Mehnert, et al.
Pharmaceutical Research|April 1, 1997
Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactantR H Müller, D Rühl, S Runge, et al.
Skin Pharmacology and Physiology|February 25, 2011
Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoidsP Schlupp, T Blaschke, K D Kramer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 24, 2004
Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptakeR Sivaramakrishnan, C Nakamura, W Mehnert, et al.
International Journal of Pharmaceutics|April 4, 2006
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystalsR H Müller, S Runge, V Ravelli, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 7, 2007
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporationR H Müller, S A Runge, V Ravelli, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|March 4, 2000
Solid lipid nanoparticles as drug carriers for topical glucocorticoidsC S Maia, W Mehnert, M Schäfer-Korting
Journal of Microencapsulation|July 21, 2006
Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLCE B Souto, W Mehnert, R H Müller
Journal of Drug Targeting|January 1, 1996
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407R H Müller, S Maassen, H Weyhers, et al.
Pharmaceutical Research|September 1, 1996
Atomic force microscopy studies of solid lipid nanoparticlesA zur Mühlen, E zur Mühlen, H Niehus, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 19, 2007
In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical useS Lombardi Borgia, P Schlupp, W Mehnert, et al.
Pharmaceutical Research|April 1, 1997
Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactantR H Müller, D Rühl, S Runge, et al.
Skin Pharmacology and Physiology|February 25, 2011
Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoidsP Schlupp, T Blaschke, K D Kramer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 24, 2004
Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptakeR Sivaramakrishnan, C Nakamura, W Mehnert, et al.
International Journal of Pharmaceutics|April 4, 2006
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystalsR H Müller, S Runge, V Ravelli, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 7, 2007
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporationR H Müller, S A Runge, V Ravelli, et al.
Pageof 3